Suraj Kalia
Stock Analyst at Oppenheimer
(3.62)
# 764
Out of 4,884 analysts
79
Total ratings
45.59%
Success rate
8.46%
Average return
Main Sectors:
Stocks Rated by Suraj Kalia
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TMDX TransMedics Group | Maintains: Outperform | $130 → $150 | $129.19 | +16.11% | 11 | Jun 17, 2025 | |
| ATRC AtriCure | Maintains: Outperform | $36 → $45 | $31.76 | +41.69% | 7 | Feb 13, 2025 | |
| VREX Varex Imaging | Maintains: Outperform | $30 → $23 | $8.80 | +161.36% | 6 | Feb 7, 2025 | |
| IRTC iRhythm Technologies | Maintains: Outperform | $105 → $120 | $142.47 | -15.77% | 5 | Jan 8, 2025 | |
| AORT Artivion | Maintains: Outperform | $30 → $32 | $30.72 | +4.17% | 3 | Nov 8, 2024 | |
| LMAT LeMaitre Vascular | Reiterates: Outperform | $90 → $93 | $84.39 | +10.20% | 2 | Nov 1, 2024 | |
| ABT Abbott Laboratories | Initiates: Outperform | $130 | $134.44 | -3.30% | 1 | Oct 8, 2024 | |
| TLSI TriSalus Life Sciences | Initiates: Outperform | $10 | $5.07 | +97.24% | 1 | Sep 16, 2024 | |
| EW Edwards Lifesciences | Maintains: Outperform | $90 | $76.79 | +17.20% | 5 | Sep 12, 2024 | |
| NYXH Nyxoah | Maintains: Outperform | $15 → $13 | $7.77 | +67.31% | 4 | Aug 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $135 | $121.00 | +11.57% | 1 | Jul 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Perform | n/a | $256.96 | - | 6 | Jun 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $24 → $30 | $10.13 | +196.15% | 5 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $16 → $10 | $0.18 | +5,486.59% | 1 | Jun 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $97 | $76.07 | +27.51% | 1 | May 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $28 | $22.84 | +22.59% | 4 | Mar 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $4.5 | $1.94 | +131.96% | 1 | Nov 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $16 | $2.28 | +601.75% | 1 | Sep 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Perform | n/a | $544.47 | - | 3 | Apr 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $660 | $2.57 | +25,580.93% | 2 | Nov 17, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Perform | n/a | $128.48 | - | 2 | Nov 3, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Perform | n/a | $5.32 | - | 1 | Sep 15, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $100 | $31.01 | +222.48% | 1 | Jun 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Market Perform | n/a | $82.93 | - | 5 | Sep 12, 2018 |
TransMedics Group
Jun 17, 2025
Maintains: Outperform
Price Target: $130 → $150
Current: $129.19
Upside: +16.11%
AtriCure
Feb 13, 2025
Maintains: Outperform
Price Target: $36 → $45
Current: $31.76
Upside: +41.69%
Varex Imaging
Feb 7, 2025
Maintains: Outperform
Price Target: $30 → $23
Current: $8.80
Upside: +161.36%
iRhythm Technologies
Jan 8, 2025
Maintains: Outperform
Price Target: $105 → $120
Current: $142.47
Upside: -15.77%
Artivion
Nov 8, 2024
Maintains: Outperform
Price Target: $30 → $32
Current: $30.72
Upside: +4.17%
LeMaitre Vascular
Nov 1, 2024
Reiterates: Outperform
Price Target: $90 → $93
Current: $84.39
Upside: +10.20%
Abbott Laboratories
Oct 8, 2024
Initiates: Outperform
Price Target: $130
Current: $134.44
Upside: -3.30%
TriSalus Life Sciences
Sep 16, 2024
Initiates: Outperform
Price Target: $10
Current: $5.07
Upside: +97.24%
Edwards Lifesciences
Sep 12, 2024
Maintains: Outperform
Price Target: $90
Current: $76.79
Upside: +17.20%
Nyxoah
Aug 7, 2024
Maintains: Outperform
Price Target: $15 → $13
Current: $7.77
Upside: +67.31%
Jul 16, 2024
Initiates: Outperform
Price Target: $135
Current: $121.00
Upside: +11.57%
Jun 25, 2024
Downgrades: Perform
Price Target: n/a
Current: $256.96
Upside: -
Aug 8, 2023
Maintains: Outperform
Price Target: $24 → $30
Current: $10.13
Upside: +196.15%
Jun 23, 2023
Maintains: Outperform
Price Target: $16 → $10
Current: $0.18
Upside: +5,486.59%
May 16, 2023
Initiates: Outperform
Price Target: $97
Current: $76.07
Upside: +27.51%
Mar 6, 2023
Reiterates: Outperform
Price Target: $28
Current: $22.84
Upside: +22.59%
Nov 29, 2022
Initiates: Outperform
Price Target: $4.5
Current: $1.94
Upside: +131.96%
Sep 24, 2021
Initiates: Outperform
Price Target: $16
Current: $2.28
Upside: +601.75%
Apr 21, 2021
Upgrades: Perform
Price Target: n/a
Current: $544.47
Upside: -
Nov 17, 2020
Upgrades: Outperform
Price Target: $660
Current: $2.57
Upside: +25,580.93%
Nov 3, 2020
Upgrades: Perform
Price Target: n/a
Current: $128.48
Upside: -
Sep 15, 2020
Initiates: Perform
Price Target: n/a
Current: $5.32
Upside: -
Jun 24, 2020
Initiates: Outperform
Price Target: $100
Current: $31.01
Upside: +222.48%
Sep 12, 2018
Upgrades: Market Perform
Price Target: n/a
Current: $82.93
Upside: -